Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Progynova 2mg

Generic: Estradiol Valerateby Bayer Zydus Pharma

Buy Progynova 2mg (Estradiol Valerate) online | SafeRxPills

Strength

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Dronis 20 (Drospirenone/Ethinylestradiol) online | SafeRxPills

Dronis 20

$15.00View
Buy Crisanta (Ethinylestradiol/Drospirenone) online | SafeRxPills

Crisanta

$16.50View
Buy Diane 35 (Cyproterone Acetate/Ethinyl Estradiol) online | SafeRxPills

Diane 35

$18.90View
Buy Femilon (Ethinyl Estradiol/Desogestrel) online | SafeRxPills

Femilon

$17.00View

About Progynova 2mg

Progynova 2mg is an estradiol valerate 2 mg tablet, sold in India in strips of 28. Estradiol valerate is broken down in the body to estradiol, which the UK label describes as chemically and biologically identical to the body's own estradiol (UK label 5.1). It is oestrogen-only hormone replacement therapy (HRT) for menopause symptoms such as hot flushes and night sweats, and in the UK it is also licensed to prevent osteoporosis in some women after the menopause. We sell it as 28 tablets for $37.50 or 56 tablets for $62.50, from $1.12 a tablet before shipping.

Four points first. The UK label says treatment of menopause symptoms "should be initiated with Progynova 1 mg", and that the 2 mg tablet should be used "If considered necessary"; 2 mg a day is the UK dose for preventing osteoporosis. If you still have a womb (uterus), oestrogen alone raises the risk of womb cancer, so the UK label says a progestogen should be added for at least 12 to 14 days of every 28 day cycle. Progynova is not a contraceptive: the UK label says it "is not suitable as a contraceptive", although our old listing said otherwise. And in the US, generic estradiol 2 mg tablets cost pharmacies about 8 cents a tablet, far less than ours, so US readers with a prescription should compare local prices first. Clinical facts on this page come from the current UK Progynova 2 mg label (Bayer plc) and, for US wording, a current US estradiol tablet label, both listed at the end. The Indian pack itself has not been tested in a published trial that we know of.

Progynova 2mg at a glance

Active ingredientEstradiol valerate 2 mg per tablet (about 1.5 mg of estradiol by molecular weight; our arithmetic)
Brand and makerProgynova, strip of 28 tablets. Tata 1mg names Bayer Zydus Pharma Pvt Ltd as marketer; PharmEasy and Apollo Pharmacy name Dr. Reddy's Laboratories, which announced on 18 February 2026 that it had bought the Progynova trademark for India. The strip may carry either name
What it is forUK label: HRT for oestrogen deficiency symptoms in women around and after the menopause, and prevention of osteoporosis after the menopause in women at high risk of fractures who cannot take, or cannot tolerate, other osteoporosis medicines (4.1)
Regulatory statusProgynova 2 mg is licensed in the UK (Bayer plc, prescription only) and Australia (ARTG 323720, prescription only). The FDA has approved no estradiol valerate tablet for HRT, and Health Canada's database lists no marketed estradiol valerate product. We found no registration of the Indian pack with the FDA, MHRA, TGA or Health Canada
Usual dose from the labelUK: one tablet a day, taken continuously, with the next pack started straight away (4.2). Menopause symptoms: start on 1 mg; 2 mg if considered necessary. Osteoporosis prevention: 2 mg a day
Half-lifeExcretion half-life about 27 hours; peak estradiol levels 0.5 to 3 hours after a dose (UK 5.2)
Packs28 tablets (4 weeks at one a day) or 56 tablets (8 weeks)
Price per tablet$1.34 (28 pack) and $1.12 (56 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per tablet

Prices below are as of October 2026; the pack selector shows the current price.

PackPricePer tabletShippingPer tablet with shippingLasts at one a day
28 tablets$37.50$1.34$25$2.2328 days
56 tablets$62.50$1.12$25$1.5656 days
Three 56 packs in one order (168 tablets)$187.50$1.12Free$1.12168 days

The 56 pack is cheaper per tablet even before shipping ($1.12 against $1.34). Both single packs are under $149, so each pays $25 shipping; an order of three 56 packs ($187.50) ships free. The days column is our arithmetic at the label dose of one tablet a day.

Your dose is your doctor's decision, and the UK label says the risks and benefits should be reviewed at least once a year (4.4). If you are just starting HRT, the UK label expects you to start on 1 mg, so do not buy a large stock of 2 mg tablets before your dose is settled. Check the expiry date on each strip when it arrives.

Compared with US, UK and Australian prices

Progynova 2mg (India, from us)Generic estradiol 2 mg tablet (US)Progynova 2mg (UK, NHS)Progynova 2mg (Australia, PBS)
Active ingredientEstradiol valerate 2 mgEstradiol 2 mg (not the valerate ester; see below)Estradiol valerate 2 mgEstradiol valerate 2 mg
Licensed thereNo (Indian pack)Yes, FDA approved generics, prescription onlyYes, Bayer plc, PL 00010/0557, prescription only (POM)Yes, ARTG 323720, prescription only (Schedule 4)
Cost$1.12 to $1.34 per tablet before shippingNADAC $0.07763 per tablet, about $2.17 for 28 (our arithmetic)NHS indicative price 730p (£7.30) for 84 tablets, about 8.7p a tablet (our arithmetic)PBS dispensed price A$18.74 for 56 tablets

NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. The rows for generic estradiol 2 mg tablets were $0.07763 a tablet, effective 21 October 2026, so by our arithmetic our tablet costs roughly 14 to 17 times that rate, tablet for tablet, before shipping. If you are in the US and have a prescription, compare US generic cash prices first. The NHS figure is what the NHS pays for the medicine, not a shop price, and the PBS figure is the Australian dispensed price; in both countries the licensed product on prescription is likely, by our estimate, to cost you less than ordering from us.

There is no US Progynova. The FDA has approved no estradiol valerate tablet for HRT. Oral estradiol valerate is approved in the US only inside Natazia, a combined contraceptive pill with dienogest, and its generic; estradiol valerate on its own is approved only as an injection (Delestrogen and generics). US women on oral HRT take estradiol tablets instead. The Estrace brand of estradiol tablets is listed by the FDA as discontinued, with a Federal Register determination that it was not withdrawn for reasons of safety or effectiveness; generic estradiol tablets in 0.5, 1 and 2 mg are current.

Estradiol 2 mg is not the same dose as estradiol valerate 2 mg. Part of each estradiol valerate molecule is the valerate group, so by molecular weight 2 mg of estradiol valerate holds about 1.5 mg of estradiol (our arithmetic from PubChem molecular weights, 272.4 for estradiol and 356.5 for estradiol valerate). Neither label gives a conversion between the two products, so moving from one to the other is a decision for your doctor.

What Progynova is used for

After the menopause, the ovaries make far less oestrogen. Progynova replaces some of it. The licensed uses are:

  • UK (Progynova 2 mg, section 4.1): "Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in peri- and postmenopausal women", and "Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis."
  • US (estradiol tablets, Indications and Usage): moderate to severe hot flushes and night sweats, and moderate to severe vulval and vaginal atrophy, associated with the menopause; low oestrogen due to hypogonadism, removal of the ovaries or primary ovarian failure; prevention of osteoporosis; and palliative treatment of some breast and prostate cancers. These are the uses of US estradiol tablets, not of Progynova.

How quickly it works. The UK label says relief of menopausal symptoms "was achieved during the first few weeks of treatment" (5.1).

Vaginal dryness on its own. The US estradiol tablet label says: "When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered." If dryness or pain during sex is your only symptom, ask a doctor about vaginal products first.

Bones. The UK label says oestrogens prevent bone loss after the menopause, protection appears to last as long as treatment continues, and after stopping, bone is lost at a rate similar to untreated women (5.1). The US label says that when estradiol is prescribed only to prevent osteoporosis, it should be considered only for women at significant risk for whom non-oestrogen medicines are not considered appropriate.

Not a contraceptive. The UK label says Progynova "is not suitable as a contraceptive" and that ovulation is not inhibited (4.4, 5.1). The UK patient leaflet says that if it is less than 12 months since your last period, or you are under 50, you may still need additional contraception; the label says to use non-hormonal methods if contraception is appropriate (4.4). Our old listing named contraception as a use. That was wrong.

Other uses. One Indian listing (Apollo Pharmacy) also mentions fertility treatment. That use is not in the UK label, and this page gives no doses for it; follow the specialist who prescribes it.

Which strength to choose

Daily doseProductHow it fits the labels
1 mgProgynova 1mgUK: treatment of menopausal symptoms "should be initiated with Progynova 1 mg" (4.2). US estradiol tablets (a different product, dosed as estradiol, not estradiol valerate): "The usual initial dosage range is 1 to 2 mg daily"
2 mgProgynova 2mgUK: for symptoms "If considered necessary"; the UK dose for preventing osteoporosis (4.2)
More than 2 mg (for example two tablets)NoneNot a UK Progynova dose: the label gives one tablet a day. UK 4.4: "For oral doses of estradiol > 2mg ... the endometrial safety of added progestogens has not been demonstrated"

The UK label adds: "Once treatment is established the lowest effective dose necessary for relief of symptoms should be used." The US label says to start at the lowest dose for the indication and to try to stop or taper at 3 to 6 month intervals. Every change of dose is your doctor's decision; never take two tablets a day on your own.

Estogel is an estradiol gel we sell, applied to the skin as oestrogen-only HRT. Do not use it together with Progynova, or with any other oestrogen, unless a doctor has told you to.

How to take Progynova 2mg

  • Once a day: one tablet a day, at the same time each day. The UK label says it does not matter what time you choose, but once chosen, keep to it (4.2).
  • No break between packs: the UK label says treatment is continuous, so the next pack follows immediately without a break (4.2). The US estradiol tablet label describes cyclic use instead ("e.g., 3 weeks on and 1 week off") for menopause symptoms. The two labels differ, so follow the schedule your prescriber gives you.
  • Food: with or without food. Swallow the tablet whole with a glass of water or milk (UK 4.2).

When to start (UK 4.2). If you have a womb and still have periods, start the combined regimen with Progynova and a progestogen on the first day of bleeding. If periods are very infrequent or have stopped, you may start at any time once pregnancy has been excluded where appropriate. If you are moving from continuous combined HRT, start on any day. If you are moving from cyclic or continuous sequential HRT, finish the current cycle and change without a break.

Missed tablet (UK 4.2 and patient leaflet). If you are less than 12 hours late, take it as soon as possible and take the next tablet at the usual time. If you are more than 12 hours late, leave the forgotten tablet in the pack and carry on with the rest at the usual time. A missed dose may cause breakthrough bleeding or spotting.

Before surgery. The UK label recommends temporarily stopping HRT 4 to 6 weeks before elective surgery that will be followed by prolonged immobilisation, and not restarting until you are completely mobile (4.4). The UK leaflet says to tell the surgeon you take Progynova. The US label says: "If feasible, estrogens should be discontinued at least 4 to 6 weeks before surgery of the type associated with an increased risk of thromboembolism, or during periods of prolonged immobilization."

Stopping. The UK leaflet says menopause symptoms such as hot flushes, trouble sleeping, nervousness, dizziness or vaginal dryness may come back, and to ask your doctor or pharmacist if you want to stop.

Reviews. The UK label says HRT should only be started for symptoms that adversely affect quality of life, and that risks and benefits should be reviewed at least annually (4.4). The US label says patients should be re-evaluated periodically, for example at 3 to 6 month intervals, to see whether treatment is still needed, and the US patient information advises a breast exam and mammogram every year unless your healthcare provider says otherwise.

Special groups (UK 4.2). Liver impairment: close supervision, and HRT should be stopped if liver markers worsen; it is contraindicated with present or past liver tumours and severe liver disease. Older women: no data suggest a need for a dose change. Kidney impairment: not specifically studied. Children and adolescents: not indicated.

If you have a womb: you need a progestogen as well

Oestrogen on its own makes the lining of the womb grow. The UK label says the reported increase in womb cancer risk among oestrogen-only users "varies from 2- to 12-fold greater compared with non-users, depending on the duration of treatment and oestrogen dose", and that after stopping, the risk may remain raised for at least 10 years (4.4). The US estradiol tablet label gives the same 2 to 12 fold figure, 15 to 24 fold with use for five to ten years or more, and says the risk persists for 8 to over 15 years after stopping (Warnings 2a). The UK label puts the background risk at about 5 in every 1,000 women with a womb not using HRT, and says that, depending on duration and dose, the increase with oestrogen-only HRT in epidemiology studies "varied from between 5 and 55 extra cases diagnosed in every 1000 women between the ages of 50 and 65" (4.8).

  • UK 4.2: "In women with an intact uterus, a progestogen should be added to Progynova for at least 12 - 14 days each month/28 day cycle."
  • UK 4.4: a progestogen for at least 12 days per cycle, or continuous combined treatment, "prevents the excess risk associated with oestrogen-only HRT". In the Million Women Study, five years of combined HRT did not increase womb cancer risk (4.8).
  • US label (Dosage and Administration): "When estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be initiated to reduce the risk of endometrial cancer. A woman without a uterus does not need progestin."
  • After a hysterectomy: the UK label says adding a progestogen is not recommended unless there is a previous diagnosis of endometriosis (4.2), and that it should be considered if endometriosis is known to remain after a hysterectomy done for endometriosis (4.4). The US label says the same for residual endometriosis.
  • Bleeding: breakthrough bleeding and spotting may occur in the first months. If it starts after some time on treatment, or continues after stopping, the cause should be investigated, which may include an endometrial biopsy (UK 4.4).

Which progestogen, at what dose and on what schedule, is your doctor's decision. We sell progesterone capsules such as Susten 100mg and Susten 200mg, but do not choose a progestogen or a dose yourself.

Medicines that interact with Progynova

  • Medicines that can lower oestrogen levels (UK 4.5): anticonvulsants such as barbiturates, phenytoin, primidone and carbamazepine; anti-infectives such as rifampicin, rifabutin, nevirapine and efavirenz; and possibly felbamate, griseofulvin, oxcarbazepine, topiramate and St John's wort. The result can be a weaker effect and changes in bleeding. The UK label says this enzyme effect can be seen after a few days, peaks within a few weeks, and may last about 4 weeks after the other medicine is stopped.
  • Medicines that can raise oestrogen levels (UK 4.5): strong and moderate CYP3A4 inhibitors, such as fluconazole, itraconazole, ketoconazole, voriconazole, verapamil, clarithromycin, erythromycin, diltiazem and grapefruit juice.
  • HIV medicines: many HIV protease inhibitor and non-nucleoside combinations can raise or lower oestrogen levels, so their own prescribing information should be checked (UK 4.5). The US label lists ritonavir among the CYP3A4 inhibitors that may raise oestrogen levels.
  • Hepatitis C medicines (ombitasvir, paritaprevir and ritonavir plus dasabuvir, with or without ribavirin; glecaprevir with pibrentasvir; sofosbuvir, velpatasvir and voxilaprevir): the UK label says caution is warranted (4.4, 4.5).
  • Lamotrigine: the UK label expects HRT may lower lamotrigine levels and so reduce seizure control (4.5).
  • Thyroid hormone: the US label says women on thyroid replacement may need a higher dose and should have thyroid function monitored.
  • Blood tests: sex hormones can change some liver, thyroid, adrenal, kidney, lipid, glucose and clotting test results (UK 4.5), so tell whoever orders your tests that you take HRT.

Tell your doctor and pharmacist about every medicine and herbal product you use.

Side effects

The UK label lists side effects reported with Progynova and other oral HRT but gives no frequencies for them (4.8). They include:

  • Breast and womb: breast tenderness, enlargement or pain, breast secretion, breakthrough bleeding and spotting (which usually settle with continued treatment), changes in bleeding pattern, painful periods, premenstrual-like symptoms, vaginal thrush and larger uterine fibroids
  • Stomach and gut: indigestion, abdominal pain, nausea, vomiting, bloating and wind; gallbladder disease
  • Head and mood: headache, migraine, dizziness, tiredness, anxiety or depressive symptoms, changes in sex drive
  • Other: fluid retention (oedema), weight change, increased appetite, high blood pressure, palpitations, muscle cramps and leg pain, nosebleeds, visual disturbances, discomfort with contact lenses, rashes, itching, acne, hair loss or unwanted hair growth, and chloasma (patches of darker skin, mostly on the face)

The US estradiol tablet patient information lists headache, breast pain, irregular vaginal bleeding or spotting, stomach cramps and bloating, nausea and vomiting, and hair loss as common side effects. If you have a tendency to chloasma, the UK label advises limiting sun and ultraviolet exposure (4.4).

Long term risks and the US boxed warning

The UK label gives these estimates, mostly from large studies of HRT in general rather than of Progynova alone (4.8):

Risk (UK label 4.8)Oestrogen-only HRTCombined oestrogen and progestogen HRT
Extra breast cancers per 1,000 users after 5 years, starting at age 50 (meta-analysis)2.78.0
Extra breast cancers per 1,000 users after 10 years, starting at age 50 (meta-analysis)7.120.8
Extra blood clots in a vein per 1,000 women aged 50 to 59 over 5 years (WHI, oral HRT; the oestrogen-only figure is from women without a womb)15

Selected figures. The breast cancer rows are for women with a BMI of 27, and the label also gives WHI breast cancer estimates.

  • Blood clots in a vein: HRT is associated with a 1.3 to 3 fold risk, more likely in the first year (UK 4.4).
  • Stroke: up to 1.5 fold for ischaemic stroke with both types of HRT; the overall risk rises with age. For women aged 50 to 59, the WHI studies combined showed about 3 extra strokes per 1,000 over 5 years (UK 4.4, 4.8).
  • Heart disease: no evidence from randomised trials that HRT protects against heart attack; combined HRT slightly raises the risk, and randomised data found no increased risk with oestrogen-only HRT in women who had a hysterectomy (UK 4.4).
  • Ovarian cancer: a slightly increased risk; for women aged 50 to 54 taking 5 years of HRT, about 1 extra case per 2,000 users (UK 4.8).
  • Dementia: "HRT use does not improve cognitive function", and there is some evidence of increased risk of probable dementia in women who start oestrogen-only or continuous combined HRT after 65 (UK 4.4).

The US label. The US estradiol tablet label we used (Epic Pharma, DailyMed version 13, effective 26 February 2026, checked 21 October 2026) carries a boxed warning headed "ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER" and "CARDIOVASCULAR AND OTHER RISKS". It says that estrogens with or without progestins "should not be used for the prevention of cardiovascular disease", and should be prescribed "at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman".

FDA label changes in progress. On 10 November 2025 the FDA asked makers of menopausal hormone therapy to remove the boxed warning language on cardiovascular disease, breast cancer and probable dementia, to "Remove the recommendation to use the lowest effective dose for the shortest amount of time", and to "Retain the Boxed Warning about endometrial cancer in the systemic estrogen-alone products". Estradiol tablets are a systemic estrogen-alone product. On 12 February 2026 the FDA announced it had approved the changes for a "first batch of six products". The US estradiol tablet labels we checked on DailyMed had not yet been updated, so this page quotes the current label.

When to get urgent help

Call emergency services (911 in the US and Canada, 999 in the UK, 000 in Australia) for possible signs of a blood clot, stroke, heart attack or severe allergic swelling (angioedema). The UK patient leaflet says to stop taking Progynova and see a doctor immediately, and the US patient information says to call your doctor immediately; calling emergency services for these symptoms is our advice.

  • painful swelling of a leg, sudden pain in the chest, or breathlessness (UK 4.4); the UK leaflet says painful swelling and redness of the legs, sudden chest pain and difficulty in breathing
  • pains in the calves or chest, sudden shortness of breath, or coughing blood (US patient information)
  • severe headache or vomiting, dizziness, faintness, changes in vision or speech, or weakness or numbness of an arm or leg (US patient information)
  • a pain in your chest that spreads to your arm or neck: the UK leaflet says to see a doctor as soon as possible and not to take any more HRT until your doctor says you can
  • sudden partial or complete loss of vision, bulging of an eye, double vision or migraine: the US label says to stop pending an eye examination (Warnings 6)
  • swollen face, tongue or throat, difficulty swallowing, or hives together with difficulty breathing, which the UK leaflet says suggest angioedema; stop taking it and get help at once

Stop taking it and see a doctor immediately (UK patient leaflet; UK 4.4 lists these as reasons to stop treatment) for:

  • yellowing of the skin or the whites of the eyes (jaundice) or worsening liver function
  • a large rise in blood pressure (symptoms may be headache, tiredness or dizziness)
  • a first migraine-type headache
  • pregnancy: the UK label says treatment should be withdrawn immediately (4.6)

Call your doctor right away about a breast lump or unusual vaginal bleeding (US patient information). If you have high blood fats (triglycerides), the UK label reports rare cases of pancreatitis in that group (4.4), so we suggest seeing a doctor promptly for severe pain in the upper abdomen. If you or a child takes too many tablets, the UK label says overdose may cause nausea, vomiting and withdrawal bleeding, with no specific antidote (4.9); the US label says serious ill effects have not been reported after young children swallowed large doses of oestrogen-containing contraceptive pills. Ask a doctor, pharmacist or poison line (1-800-222-1222 in the US, 13 11 26 in Australia, NHS 111 in the UK) for advice, and tell them what was taken, how much and when.

Who should not take Progynova 2mg

Never take it if you have any of the UK label contraindications (4.3):

  • known, past or suspected breast cancer
  • known or suspected oestrogen-dependent cancer, such as endometrial cancer
  • genital bleeding that a doctor has not diagnosed
  • untreated thickening of the womb lining (endometrial hyperplasia)
  • a past unexplained or current blood clot in a vein (deep vein thrombosis or pulmonary embolism)
  • a known clotting disorder, such as protein C, protein S or antithrombin deficiency
  • active or recent arterial disease, such as angina or a heart attack; the US label says active or recent (for example within the past year) arterial disease such as a stroke or heart attack
  • acute liver disease, or past liver disease while liver tests have not returned to normal; the UK label also contraindicates present or past liver tumours and severe liver disease (4.2), and the US label says liver dysfunction or disease
  • allergy to estradiol valerate or any ingredient of the tablet
  • porphyria

Not for use in pregnancy or breastfeeding: the UK label says Progynova "is not indicated during pregnancy" or "during breast-feeding" (4.6); the US label lists known or suspected pregnancy as a contraindication.

Sugars in the tablet. The UK tablet contains lactose and sucrose. The UK label says people with rare hereditary problems of fructose intolerance, galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption or sucrose-isomaltase insufficiency "should not take this medicine" (4.4). We have not confirmed the excipients of the Indian tablet, so read the leaflet in the pack.

Talk to a doctor first, and expect closer supervision, if you have or have had any of the following (UK 4.4):

  • uterine fibroids or endometriosis
  • risk factors for blood clots, such as obesity (BMI over 30), older age, lupus, cancer, or a close relative who had a clot at a young age
  • risk factors for oestrogen-dependent cancers, such as breast cancer in a mother, sister or daughter
  • high blood pressure, diabetes, gallstones, or liver problems such as a liver adenoma
  • migraine or severe headaches, epilepsy or asthma
  • past endometrial hyperplasia, otosclerosis (a hearing condition) or hereditary angioedema
  • heart or kidney problems that cause fluid retention, or high triglycerides
  • heart disease now or recently: the UK patient leaflet says HRT is not recommended for women who have heart disease, or have had heart disease recently
  • anticoagulant treatment, which needs careful weighing of benefit and risk

Not for preventing heart disease or memory loss. The US boxed warning says estrogens with or without progestins "should not be used for the prevention of cardiovascular disease", and the UK label says "HRT use does not improve cognitive function" (4.4).

Prescription and legal status

  • US: no estradiol valerate HRT tablet is FDA approved. Estradiol tablets are approved generics, prescription only. The Indian Progynova pack is not registered with the FDA. The FDA says personal importation of unapproved medicines is illegal in most circumstances.
  • UK: Progynova 2 mg Tablets (Bayer plc, PL 00010/0557) is a prescription-only medicine (POM). Other UK estradiol valerate 2 mg tablets include Climaval and generics. The Indian pack is not the one licensed in the UK.
  • Australia: Progynova 2 mg is on the ARTG (323720), Schedule 4 (prescription only), and on the PBS (item 1664N). We found no ARTG entry for the Indian pack.
  • Canada: every estradiol valerate product in Health Canada's Drug Product Database is cancelled, and none was a tablet for HRT. Oral estradiol tablets, such as Lupin-Estradiol (DIN 02449064), are marketed as prescription medicines. We found no DIN for Progynova.
  • India: the Tata 1mg listing marks Progynova 2mg as prescription required.

Oral HRT is prescription only everywhere we checked, because a doctor needs to check your history and contraindications, decide whether you need a progestogen, and review you regularly. See a doctor before you take it, and check the rules where you live.

Buying genuine Progynova

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers the Indian Progynova pack, which is not authorised in the UK. When your order arrives, check that the strip names Progynova and estradiol valerate 2 mg, names a maker (Bayer Zydus Pharma or Dr. Reddy's Laboratories, since the Indian listings differ), and shows a batch number and an expiry date. These checks cannot prove that a strip is genuine, because counterfeiters copy packaging. The UK label gives no special storage conditions (6.4); Indian listings say store below 25 C (PharmEasy) or below 30 C (Tata 1mg). Keep it out of the reach of children. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Progynova 2mg to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. Both of our packs are under $149, so a single pack pays shipping; three 56 packs in one order ship free. Because treatment is daily and continuous, order your next pack two to three weeks before the current strip runs out. See our shipping page and refund policy.

Related guides

Sources

  • Progynova 2 mg Tablets, Summary of Product Characteristics, Bayer plc, PL 00010/0557, text revised 7 September 2026: sections 2, 3, 4.1 to 4.9, 5.1, 5.2, 6.1, 6.3 to 6.5. emc
  • Progynova 2 mg Tablets, Patient Information Leaflet, Bayer plc, last revised March 2026. emc
  • Estradiol Tablets USP 0.5 mg, 1 mg and 2 mg, US prescribing information and Patient Information, Epic Pharma LLC, DailyMed setid 9333d92f-2585-4b99-aaea-87c01c95125e, version 13, effective 26 February 2026: Boxed Warning, Indications and Usage, Contraindications, Warnings, Precautions, Adverse Reactions, Overdosage, Dosage and Administration. DailyMed
  • US Food and Drug Administration. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies (10 November 2025, updated 12 February 2026). FDA
  • US Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, 12 February 2026. FDA
  • Drugs@FDA via openFDA, checked 21 October 2026: estradiol valerate products (Delestrogen NDA009402 and generic injections; Natazia NDA022252 and generic ANDA202349); Estrace tablets ANDA084499 and ANDA084500 (discontinued); generic estradiol tablets (for example ANDA040197). openFDA
  • CMS National Average Drug Acquisition Cost (NADAC), estradiol 2 mg tablet, $0.07763 per tablet, effective 21 October 2026 (10 NDCs). Medicaid.gov
  • NHS Dictionary of Medicines and Devices (dm+d): Progynova 2mg tablets, 84 tablet (3 x 28), NHS indicative price 730p, POM. NHSBSA
  • Therapeutic Goods Administration, ARTG 323720: PROGYNOVA estradiol valerate 2 mg tablet blister pack. TGA
  • healthdirect: Progynova, Schedule 4 Prescription Only Medicine, 56 tablets. healthdirect
  • Pharmaceutical Benefits Scheme, item 1664N: estradiol valerate 2 mg tablet, 56, dispensed price A$18.74, brand Progynova. PBS
  • Health Canada Drug Product Database, checked 21 October 2026: estradiol valerate products (all cancelled); Lupin-Estradiol, DIN 02449064, marketed, prescription. Health Canada
  • PubChem: estradiol valerate (CID 13791, molecular weight 356.5) and estradiol (CID 5757, 272.4). PubChem
  • Dr. Reddy's Laboratories press release, 18 February 2026: acquisition of the Progynova and CycloProgynova trademarks for India from Mercury Pharma Group. Dr. Reddy's
  • PharmEasy listing: Progynova 2mg, estradiol valerate 2.0 mg, strip of 28, Dr. Reddy's Laboratories, store below 25 C. PharmEasy
  • Tata 1mg listing: Progynova 2mg, strip of 28 tablets, Bayer Zydus Pharma Pvt Ltd, prescription required, store below 30 C. Tata 1mg
  • Apollo Pharmacy listing: Progynova 2 mg tablet 28's, Dr. Reddy's Laboratories. Apollo Pharmacy
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Progynova should be taken only after a doctor has checked whether HRT is suitable for you and whether you also need a progestogen.

Frequently asked questions

What is Progynova 2mg?

Progynova 2mg is an estradiol valerate 2 mg tablet, sold in India in strips of 28. Estradiol valerate is broken down in the body to estradiol. It is oestrogen-only hormone replacement therapy (HRT): the UK label licenses Progynova 2 mg for oestrogen deficiency symptoms around and after the menopause, and for preventing osteoporosis after the menopause in women at high risk of fractures who cannot take, or cannot tolerate, other osteoporosis medicines. It needs a prescription and regular review by a doctor.

Is the Indian Progynova 2mg the same as the UK Progynova?

Both contain estradiol valerate 2 mg under the Progynova name, but they are different packs. UK Progynova 2 mg is licensed to Bayer plc (PL 00010/0557). Indian listings name Bayer Zydus Pharma (Tata 1mg) or Dr. Reddy's Laboratories (PharmEasy, Apollo Pharmacy); Dr. Reddy's announced in February 2026 that it had bought the Progynova trademark for India. We have not seen data comparing the Indian tablet with the UK tablet, and we have not confirmed the Indian tablet's excipients, so read the leaflet in the pack.

How much does Progynova 2mg cost per tablet?

As of October 2026, 28 tablets cost $37.50 ($1.34 a tablet) and 56 tablets cost $62.50 ($1.12 a tablet), before shipping. Shipping is $25 on orders under $149 and free from $149, so with shipping the per tablet cost is $2.23 (28 pack) or $1.56 (56 pack). The pack selector shows the current price. In the US, generic estradiol 2 mg tablets had a NADAC rate of $0.07763 a tablet (effective 21 October 2026), so US readers with a prescription should compare local prices first.

How do I take Progynova 2mg?

The UK label says one tablet a day, at the same time each day, swallowed whole with a glass of water or milk, with or without food. Treatment is continuous: start the next pack straight away with no break. If you are less than 12 hours late with a tablet, take it as soon as possible; if you are more than 12 hours late, leave the missed tablet in the pack and carry on as usual. The US estradiol tablet label describes cyclic use (for example 3 weeks on and 1 week off), so follow the schedule your prescriber gives you.

Should I start on Progynova 1mg or 2mg?

The UK label says treatment of menopause symptoms "should be initiated with Progynova 1 mg", with 2 mg used "If considered necessary", and then the lowest effective dose that relieves symptoms. For preventing osteoporosis after the menopause, the UK dose is 2 mg a day. Your doctor decides the strength. Do not take two tablets a day: the UK label says the endometrial safety of added progestogens has not been demonstrated for oral estradiol doses above 2 mg.

Do I need a progestogen with Progynova?

If you still have a womb, yes. Oestrogen alone raises the risk of womb lining cancer: the UK label gives 2 to 12 fold, depending on dose and duration. The UK label says a progestogen should be added for at least 12 to 14 days of every 28 day cycle, and the US estradiol label says a progestin should also be started in women with a uterus. After a hysterectomy, the UK label says a progestogen is not recommended unless you had endometriosis. Which progestogen and dose is your doctor's decision.

How long does Progynova take to work, and how long can I take it?

The UK label says relief of menopause symptoms was achieved during the first few weeks of treatment. There is no fixed end date: the UK label says HRT should only be continued as long as the benefit outweighs the risk, with a review at least once a year, and the US label suggests re-evaluating at 3 to 6 month intervals. Symptoms may come back when you stop, so plan stopping with your doctor.

Is Progynova a contraceptive?

No. The UK label says Progynova "is not suitable as a contraceptive" and that ovulation is not inhibited. The UK patient leaflet says that if it is less than 12 months since your last period, or you are under 50, you may still need additional contraception, and the label says to use non-hormonal methods if contraception is appropriate. If you become pregnant while taking it, stop and contact your doctor.

What are the side effects of Progynova 2mg?

The UK label lists, without frequencies, breast tenderness or pain, breakthrough bleeding and spotting (which usually settle), headache, migraine, nausea, bloating, abdominal pain, fluid retention, weight change, mood changes and skin changes. Longer term, HRT is linked with higher risks of blood clots (1.3 to 3 fold), ischaemic stroke (up to 1.5 fold), breast cancer and ovarian cancer. Signs of a clot, such as a painful swollen leg, sudden chest pain or breathlessness, need urgent help.

Who should not take Progynova 2mg?

The UK label says never take it with known, past or suspected breast cancer, an oestrogen-dependent cancer, undiagnosed genital bleeding, untreated endometrial hyperplasia, a past unexplained or current blood clot in a vein, a known clotting disorder, active or recent arterial disease such as angina or a heart attack, acute or unresolved liver disease, liver tumours, porphyria, or allergy to any ingredient. It is not indicated in pregnancy or breastfeeding. Fibroids, endometriosis, high blood pressure, diabetes, migraine, epilepsy, asthma and lupus need closer supervision.

Do I need a prescription, and how is it delivered?

Yes. Progynova 2 mg is prescription only in the UK (POM) and Australia (Schedule 4); the FDA has approved no estradiol valerate HRT tablet, and oral estradiol tablets are prescription only in the US and Canada. We found no registration of the Indian pack with the FDA, MHRA, TGA or Health Canada, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. We ship in plain packaging with tracking in 7 to 14 business days; shipping is $25 under $149 and free from $149.

Guide to Female Infertility & Ovulation InductionHow clomiphene triggers ovulation in PCOS and anovulatory women, success rates, dosing protocol, how to time sex around Clomid, and what to do if it does not work.

Related articles

Customer Reviews

No reviews yet. Bought Progynova 2mg? Tell other buyers how it went.